<SEC-DOCUMENT>0001193125-23-190185.txt : 20230720
<SEC-HEADER>0001193125-23-190185.hdr.sgml : 20230720
<ACCEPTANCE-DATETIME>20230720083131
ACCESSION NUMBER:		0001193125-23-190185
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230718
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230720
DATE AS OF CHANGE:		20230720

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMARIN CORP PLC\UK
		CENTRAL INDEX KEY:			0000897448
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21392
		FILM NUMBER:		231098157

	BUSINESS ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60
		BUSINESS PHONE:		353 1 6699 020

	MAIL ADDRESS:	
		STREET 1:		SPACES SOUTH DOCKLANDS, BLOCK C
		STREET 2:		77 SIR JOHN ROGERSON'S QUAY
		CITY:			DUBLIN 2
		STATE:			L2
		ZIP:			D02 VK60

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMARIN PHARMACEUTICALS PLC
		DATE OF NAME CHANGE:	20000201

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ETHICAL HOLDINGS PLC
		DATE OF NAME CHANGE:	19930322
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d530487d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:amrn="http://www.amarincorp.com/20230718" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-07-18_to_2023-07-18">AMARIN CORP PLC\UK</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityTaxIdentificationNumber" name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-07-18_to_2023-07-18">00-0000000</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey_duration_2023-07-18_to_2023-07-18" name="dei:EntityCentralIndexKey" contextRef="duration_2023-07-18_to_2023-07-18">0000897448</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_AmendmentFlag_duration_2023-07-18_to_2023-07-18" name="dei:AmendmentFlag" contextRef="duration_2023-07-18_to_2023-07-18">false</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="amrn-20230718.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-07-18_to_2023-07-18"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000897448</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-07-18</xbrli:startDate> <xbrli:endDate>2023-07-18</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-07-18_to_2023-07-18">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of Earliest Event Reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt:date-monthname-day-year-en">July&#160;18, 2023</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">Amarin Corporation plc</span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen">England and Wales</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityFileNumber">0-21392</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style=" -sec-ix-hidden:Hidden_dei_EntityTaxIdentificationNumber">Not applicable</span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr> </table> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:33%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:31%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-07-18_to_2023-07-18">Iconic Offices, The Greenway</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="duration_2023-07-18_to_2023-07-18">Block C Ardilaun Court</ix:nonNumeric>,</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine3" contextRef="duration_2023-07-18_to_2023-07-18">112 - 114 St Stephens Green</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-07-18_to_2023-07-18">Dublin</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-07-18_to_2023-07-18">2</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="duration_2023-07-18_to_2023-07-18" format="ixt-sec:countrynameen">Ireland</ix:nonNumeric></p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><span style="font-weight:bold">Not applicable</span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr> </table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#x2019;s telephone number, including area code: +<ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:CountryRegion">353</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:CityAreaCode">1</ix:nonNumeric> <ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:LocalPhoneNumber">6699 020</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Former name or former address, if changed since last report</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr> </table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"><p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr> </table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"><p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-07-18_to_2023-07-18">American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1)&#160;Ordinary Share of Amarin Corporation plc</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:TradingSymbol">AMRN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen">Nasdaq Stock Market LLC</ix:nonNumeric></td></tr> </table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span></p> <p style="margin-top:8pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric contextRef="duration_2023-07-18_to_2023-07-18" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departures of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold"><span style="font-style:italic">Appointment of Patrick Holt as President and Chief Executive Officer and member of the Board of Directors </span></p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, on July&#160;18, 2023, Amarin Corporation plc (&#x201C;<span style="font-weight:bold"><span style="font-style:italic">Amarin</span></span>&#x201D; or the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">Company</span></span>&#x201D;) announced that Patrick Holt was appointed to the role of President and Chief Executive Officer (and principal executive officer) of Amarin, effective July&#160;18, 2023 (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">CEO Start Date</span></span>&#x201D;).&#160;&#160;&#160;&#160;In addition, Mr.&#160;Holt was also appointed as a member of the Amarin board of directors (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">Board</span></span>&#x201D;), effective as of the CEO Start Date.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with his appointment as President and Chief Executive Officer, Mr.&#160;Holt entered into an employment agreement with Amarin, dated July&#160;18, 2023 (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">CEO Employment Agreement</span></span>&#x201D;), which provides that, effective as of the CEO Start Date, Mr.&#160;Holt&#x2019;s annual base salary will be $675,000 and he will have the potential to earn cash incentive compensation as determined in the sole discretion of the Board or the Remuneration Committee of the Board. In connection with his appointment, Mr.&#160;Holt will be granted a performance-based stock option to purchase 5,000,000 shares (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">Option Award</span></span>&#x201D;) pursuant to the Amarin Corporation plc 2020 Stock Incentive Plan, as amended (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">Plan</span></span>&#x201D;) and the form of Option Award agreement attached to the CEO Employment Agreement (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">Option Award Agreement</span></span>&#x201D;). The Option Award is earned based upon the achievement of share price hurdles ranging from $2.50 to $15.00 and the earned option shares are subject to five months of further time-based vesting once a share price hurdle has been achieved. For each share price hurdle to be achieved, the volume weighted average price of the shares over a 60 <span style="white-space:nowrap">calendar-day</span> period must equal or exceed the applicable share price hurdle. The Option Award will have an exercise price equal to the closing price of Amarin&#x2019;s American Depository Shares on the NASDAQ Capital Market on the date of grant, which is expected to be August&#160;1, 2023, the first trading day in August. The Option Award is subject to acceleration and a clawback in certain circumstances in accordance with the terms of the Option Award Agreement. Pursuant to the CEO Employment Agreement, Mr.&#160;Holt has also agreed to purchase $300,000 worth of Amarin shares using his personal funds.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The CEO Employment Agreement provides that, if Mr.&#160;Holt&#x2019;s employment is terminated by the Company without cause or if Mr.&#160;Holt resigns for good reason, in either case outside of the Change in Control Period (as defined below), Mr.&#160;Holt will be eligible to receive the following severance benefits, subject to his execution and the effectiveness of a separation agreement, including, among other things, a general release of claims in favor of the Company (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">Separation Agreement</span></span>&#x201D;): (i) an amount equal to 18 months of his base salary and 1.5 times his target annual bonus, to be paid in equal installments over the course of 18 months following the date of termination, and (ii)&#160;subject to Mr.&#160;Holt&#x2019;s copayment of premium amounts at the applicable active employees&#x2019; rate and proper election to continue COBRA health coverage, payment of the portion of the premiums equal to the amount that the Company would have paid to provide health insurance to Mr.&#160;Holt had he remained employed until the earliest of (A) 18 months following termination, (B)&#160;Mr.&#160;Holt&#x2019;s eligibility for group medical plan benefits under any other employer&#x2019;s group medical plan or (C)&#160;the end of Mr.&#160;Holt&#x2019;s COBRA health continuation period (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">COBRA Coverage</span></span>&#x201D;). The CEO Employment Agreement also provides that if Mr.&#160;Holt&#x2019;s employment is terminated by the Company without cause or Mr.&#160;Holt resigns for good reason in either case within the <span style="white-space:nowrap">24-month</span> period following a change in control (the &#x201C;<span style="font-weight:bold"><span style="font-style:italic">Change in Control Period</span></span>&#x201D;), Mr.&#160;Holt will be eligible to receive the following severance benefits, subject to his execution and the effectiveness of a Separation Agreement: (i)&#160;an amount equal to two times his base salary and two times his target annual bonus, to be paid in a lump sum, and (ii)&#160;the COBRA Coverage.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mr.&#160;Holt will enter into a deed of indemnity with Amarin on the same form as Amarin&#x2019;s other executive officers.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no other arrangements or understandings between Mr.&#160;Holt and any other person pursuant to which Mr.&#160;Holt was appointed to the positions described in this Current Report on <span style="white-space:nowrap">Form&#160;8-K,&#160;and</span> Mr.&#160;Holt is not a party to any transaction that would require disclosure under <span style="white-space:nowrap">Item&#160;404(a)&#160;of&#160;Regulation&#160;S-K.&#160;Please</span> see the Current Report on Form <span style="white-space:nowrap">8-K</span> filed by Amarin on July&#160;18, 2023 for Mr.&#160;Holt&#x2019;s biographical information, which biography is incorporated herein by reference. The foregoing summary of the CEO Employment Agreement and the Option Award does not purport to be complete and is qualified in its entirety by reference to the CEO Employment Agreement and the Option Award Agreement, copies of which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form <span style="white-space:nowrap">8-K</span> and which are incorporated by herein by reference.</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits.</p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit<br />No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Description</span></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1<br /></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><a href="d530487dex101.htm">CEO Employment Agreement, dated July&#160;18, 2023 by and between Amarin Corporation plc and Patrick Holt </a></p></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d530487dex101.htm">Option Award Agreement (attached to Exhibit 10.1)* </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">* Certain confidential portions (indicated by brackets and asterisks) have been omitted from this Exhibit.</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">*&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;*</p></div></div> <p style='page-break-before:always'></p> <hr style="color:#999999;height:3px;width:100%" /> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0">
<tr>
<td style="width:45%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: July&#160;20, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">Amarin Corporation plc</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman"><span style="font-style:italic">/s/ Tom Reilly</span></p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Tom Reilly</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Financial Officer</td></tr></table></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d530487dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH &#147;[***]&#148;. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS
EXHIBIT BECAUSE IT IS (I)&nbsp;NOT MATERIAL AND (II)&nbsp;OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EMPLOYMENT
AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Employment Agreement (&#147;<U>Agreement</U>&#148;) is made between Amarin Corporation plc, (the
&#147;<U>Company</U>&#148;) and Patrick J. Holt (the &#147;<U>Executive</U>&#148;). Payments and benefits to the Executive under this Agreement may be satisfied by a subsidiary or affiliate of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Company desires to employ the Executive and the Executive desires to be employed by the Company beginning on or about
July&nbsp;18, 2023 (the actual start date, the &#147;<U>Effective Date</U>&#148;) on the terms and conditions contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW,
THEREFORE,<I> </I>in consideration of the mutual covenants and agreements herein contained and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Employment</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
<U>Term</U>. The Company shall employ the Executive and the Executive shall be employed by the Company pursuant to this Agreement commencing as of the Effective Date and continuing until such employment is terminated in accordance with the
provisions hereof (the &#147;<U>Term</U>&#148;). The Executive&#146;s employment with the Company shall be &#147;at will,&#148; meaning that the Executive&#146;s employment may be terminated by the Company or the Executive at any time and for any
reason subject to the terms of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Position and Duties</U>. The Executive shall serve as the President and Chief
Executive Officer (&#147;<U>CEO</U>&#148;) of the Company and shall have such powers and duties as may from time to time be prescribed by the Company&#146;s Board of Directors (the &#147;<U>Board</U>&#148;). In addition, the Company shall cause the
Executive to be nominated for election to the Board and to be recommended to the shareholders for election to the Board as long as the Executive remains the CEO; <I>provided</I> that the Executive shall be deemed to have resigned from the Board and
from any related positions upon ceasing to serve as CEO for any reason. The Executive shall devote the Executive&#146;s full working time and efforts to the business and affairs of the Company. Notwithstanding the foregoing, the Executive may serve
on other boards of directors, with the reasonable approval of the Board, or engage in religious, charitable or other community activities as long as such services and activities do not interfere with the Executive&#146;s performance of the
Executive&#146;s<B> </B>duties to the Company. In addition to the Executive&#146;s role as CEO, the Executive acknowledges and agrees that he may&nbsp;be&nbsp;required,&nbsp;without additional compensation, to perform duties for certain affiliated
entities of the Company, including, without limitation, Amarin Pharma, Inc.,&nbsp;and&nbsp;to accept any reasonable office or position with any&nbsp;such&nbsp;affiliate as&nbsp;the&nbsp;Board&nbsp;may require,&nbsp;including,&nbsp;but
not&nbsp;limited&nbsp;to, service as an officer or&nbsp;director&nbsp;of any&nbsp;such&nbsp;affiliate, provided, however, that such duties and obligations to the Company&#146;s affiliates do not unduly burden or interfere with Executives&#146;
performance as CEO of the Company. The Company shall maintain a director and officer policy (&#147;<U>D&amp;O Policy</U>&#148;) and the Executive shall be covered under the Company&#146;s D&amp;O policy. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Location</U>. The Executive&#146;s principal place of employment will be his home
office in Massachusetts, but the Executive understands that he will be required to travel frequently for business, including to the Company&#146;s U.S. headquarters, which are currently located in Bridgewater, New Jersey, and to the Company&#146;s
Irish headquarters, which are currently located in Dublin, Ireland, as well as to other locations in Europe and other parts of the world. Any change to the location of the Executive&#146;s home office must be approved in advance by the Board. The
Executive shall be reimbursed for all business travel, including, for the avoidance of doubt, all travel to and from his home office to Company&#146;s headquarters (both in the US and Ireland) and such other business locations as reasonably required
by his employment, subject to the Company&#146;s policies and procedures then in effect and established by the Company for its U.S. executives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Compensation and Related Matters</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Base Salary</U>. The Executive&#146;s initial base salary shall be paid at the rate of $675,000 per year. The Executive&#146;s base
salary shall be subject to periodic review by<B> </B>the Board or the Remuneration Committee of the Board (the &#147;<U>Remuneration Committee</U>&#148;). The Remuneration Committee may increase but not decrease the Executive&#146;s Base Salary. The
base salary in effect at any given time is referred to herein as &#147;<U>Base Salary</U>.&#148; The Base Salary shall be payable in a manner that is consistent with the Company&#146;s usual payroll practices for its executive officers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Incentive Compensation</U>. The Executive shall be eligible to receive cash incentive compensation as determined by the Board or the
Remuneration Committee from time to time. The actual amount of the Executive&#146;s cash incentive compensation, if any, shall be determined in the sole discretion of the Board or the Remuneration Committee, and may be further subject to the terms
of any applicable incentive compensation plan that may be in effect from time to time. Except as may be provided by the Board or the Remuneration Committee, or as may otherwise be set forth in the applicable incentive compensation plan or this
Agreement, the Executive must be employed by the Company on the date such cash incentive compensation is paid in order to earn or receive any cash incentive compensation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Expenses</U>. The Executive shall be entitled to receive prompt reimbursement for all reasonable expenses (including, for the avoidance
of doubt, all reasonable travel expenses incurred consistent with the policies and procedures then in effect and established by the Company for its U.S. executives) incurred by the Executive during the Term in performing services hereunder, in
accordance with the policies and procedures then in effect and established by the Company for its U.S. executives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Other
Benefits</U>. The Executive shall be eligible to participate in or receive benefits under the Company&#146;s employee benefit plans in effect from time to time, subject to the terms of such plans. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Paid Time Off</U>. The Executive shall be entitled to take paid time off in
accordance with the Company&#146;s applicable paid time off policy for its U.S. executives, as may be in effect from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f)
<U>Equity</U><B>. </B>In connection with the commencement of the Executive&#146;s employment and subject to the approval of the Board or the Remuneration Committee, the Company shall grant the Executive a stock option to purchase Five Million
(5,000,000) of the Company&#146;s Ordinary Shares or American Depositary Shares, representing ordinary shares of the Company, issued under the Company&#146;s American Depositary Receipt facility (&#147;<U>Shares</U>&#148;), subject to
performance-based vesting terms as set forth in the award agreement attached hereto as <U>Exhibit A</U> under the Amarin Corporation plc 2020 Stock Incentive Plan (the &#147;<U>Plan</U>&#148; and, together with the award agreement, the
&#147;<U>Equity Documents</U>&#148;) and with an exercise price per share equal to the closing price of a Share on the Nasdaq Global Market on the date of grant (or if no closing market price is reported for such date, the closing market price on
the immediately preceding date for which a closing market price is reported) (the &#147;<U>Option</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <U>Equity
Commitment</U>. The Executive desires to evidence his commitment and support for the Company by purchasing equity in the Company, without any present intention to transfer or otherwise transact in such equity, and the Company desires to accommodate
this commitment. As such, promptly following the Executive&#146;s and the Company&#146;s execution of this Agreement (and in any event promptly following the start of the Company&#146;s next open trading window under its insider trading policy and
special trading procedures for insiders), the Executive will purchase for cash approximately $300,000 of American Depository Shares of the Company in an open market transaction at market pricing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Termination</U>. The Executive&#146;s employment hereunder may be terminated without any breach of this Agreement under the following
circumstances: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Death</U>. The Executive&#146;s employment hereunder shall terminate upon death. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Disability</U>. The Company may terminate the Executive&#146;s employment if the Executive is disabled and unable to perform or
expected to be unable to perform the essential functions of the Executive&#146;s then existing position or positions under this Agreement with or without reasonable accommodation for a period of 180 days (which need not be consecutive) in any <FONT
STYLE="white-space:nowrap">12-month</FONT> period. If any question shall arise as to whether during any period the Executive is disabled so as to be unable to perform the essential functions of the Executive&#146;s then existing position or
positions with or without reasonable accommodation, the Executive may, and at the request of the Company shall, submit to the Company a certification in reasonable detail by a physician selected by the Company to whom the Executive or the
Executive&#146;s guardian has no reasonable objection as to whether the Executive is so disabled or how long such disability is expected to continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. The
Executive shall cooperate with any reasonable request of the physician in connection with such certification. If such question shall arise and the Executive shall fail to submit such certification, the Company&#146;s determination of such issue
shall be binding on the Executive. Nothing in this Section&nbsp;4(b) shall be construed to waive the Executive&#146;s rights, if any, under existing law including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. &#167;2601
<I>et seq</I>. and the Americans with Disabilities Act, 42 U.S.C. &#167;12101 <I>et seq.</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Termination by the Company for Cause</U>. The Company may terminate the
Executive&#146;s employment hereunder for Cause. For purposes of this Agreement, &#147;<U>Cause</U>&#148; shall mean any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) conduct constituting an act of negligence, recklessness or material misconduct in connection with the performance of the Executive&#146;s
duties, including, without limitation, misappropriation of funds or property of the Company other than the occasional, customary and de minimis use of Company property for personal purposes; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the Executive&#146;s conviction of (A)&nbsp;any felony; or (B)&nbsp;a misdemeanor involving moral turpitude, deceit, dishonesty or
fraud; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) any conduct of the Executive that results, or would reasonably be expected to result in material damages or material
reputational harm to the Company or any of its subsidiaries or affiliates if the Executive was retained; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) prior to a Change in
Control, the Executive&#146;s continued <FONT STYLE="white-space:nowrap">non-performance</FONT> or continued unsatisfactory performance of the Executive&#146;s responsibilities as reasonably determined by the Board and which remains uncured after
having been given the opportunity to cure; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) a breach by the Executive of any of the material provisions of the Restrictive Covenants
Agreement (as defined below) between the Executive and the Company that remains uncured; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) a material violation by the Executive
of any of the Company&#146;s written policies or procedures; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided that, other than in the case of noncurable events (i)-(iii) above, the Executive
shall be provided with written notice of such conduct and 30 days notice to cure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Termination by the Company without Cause</U>.
The Company may terminate the Executive&#146;s employment hereunder at any time without Cause. Any termination by the Company of the Executive&#146;s employment under this Agreement which does not constitute a termination for Cause under
Section&nbsp;4(c) and does not result from the death or disability of the Executive under Section&nbsp;4(a) or (b)&nbsp;shall be deemed a termination without Cause. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Termination by the Executive</U>. The Executive may terminate employment hereunder at any time for any reason, including but not
limited to, Good Reason. For purposes of this Agreement, &#147;<U>Good Reason</U>&#148; shall mean that the Executive has completed all steps of the Good Reason Process (hereinafter defined) following the occurrence of any of the following events
without the Executive&#146;s consent (each, a &#147;<U>Good Reason Condition</U>&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a material diminution in the
Executive&#146;s responsibilities, authority or duties; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) a material diminution in the Executive&#146;s Base Salary except for <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">across-the-board</FONT></FONT> salary reductions based on the Company&#146;s financial performance similarly affecting all or substantially all
<FONT STYLE="white-space:nowrap">C-level</FONT> and executive/senior management employees of the Company, for clarity, 5% or more diminution shall be deemed material); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) a requirement by the Company that the Executive change the principal location where the Executive is required to provide
services for the Company (not including business travel and short-term assignments) by more than fifty (50)&nbsp;miles; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) a material breach of this Agreement by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The &#147;<U>Good Reason Process</U>&#148; consists of the following steps: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Executive reasonably determines in good faith that a Good Reason Condition has occurred; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the Executive notifies the Company in writing of the first occurrence of the Good Reason Condition within 30 days of the
first occurrence of such condition; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) notwithstanding such efforts, the Good Reason Condition continues to exist at
the end of the Cure Period; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) the Executive terminates employment within 30 days after the end of the Cure Period.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company shall have thirty (30)&nbsp;days (&#147;<U>Cure Period</U>&#148;) from delivery of Executive&#146;s notice of the existence of a Good Reason
Condition to cure such breached Good Reason Condition. If the Company cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed not to have occurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Matters Related to Termination</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Notice of Termination</U>. Except for termination as specified in Section&nbsp;4(a), any termination of the Executive&#146;s employment
by the Company or any such termination by the Executive shall be communicated by written Notice of Termination to the other party hereto. For purposes of this Agreement, a &#147;<U>Notice of Termination</U>&#148; shall mean a notice that indicates
the specific termination provision in this Agreement relied upon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Date of Termination</U>. &#147;<U>Date of Termination</U>&#148;
shall mean: (i)&nbsp;if the Executive&#146;s employment is terminated by death, the date of death; (ii)&nbsp;if the Executive&#146;s employment is terminated on account of disability under Section&nbsp;4(b) or by the Company for Cause under
Section&nbsp;4(c), the date on which Notice of Termination is given, provided, however, that the Company has, prior to the issuance of the Notice of Termination pursuant to Section&nbsp;4(c), delivered written notice and provided Executive with an
opportunity to cure and such breach has not been cured within such 30 day cure period; (iii)&nbsp;if the Executive&#146;s employment is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
terminated by the Company without Cause under Section&nbsp;4(d), the date on which a Notice of Termination is given or the date otherwise specified by the Company in the Notice of Termination;
(iv)&nbsp;if the Executive&#146;s employment is terminated by the Executive under Section&nbsp;4(e) other than for Good Reason, 30 days after the date on which a Notice of Termination is given, and (v)&nbsp;if the Executive&#146;s employment is
terminated by the Executive under Section&nbsp;4(e) for Good Reason, the date on which a Notice of Termination is given after the end of the Cure Period. Notwithstanding the foregoing, in the event that the Executive gives a Notice of Termination to
the Company, the Company may unilaterally accelerate the Date of Termination and such acceleration shall not result in a termination by the Company for purposes of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Accrued Obligations</U>. If the Executive&#146;s employment with the Company is terminated for any reason, the Company shall pay or
provide to the Executive (or to the Executive&#146;s<B> </B>authorized representative or estate)&nbsp;(i) any Base Salary earned through the Date of Termination and, if applicable, any accrued but unused vacation through the Date of Termination;
(ii)&nbsp;unpaid expense reimbursements (subject to, and in accordance with, Section&nbsp;2(c) of this Agreement); and (iii)&nbsp;any vested benefits the Executive may have under any employee benefit plan of the Company through the Date of
Termination, which vested benefits shall be paid and/or provided in accordance with the terms of such employee benefit plans (collectively, the &#147;<U>Accrued Obligations</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Resignation of All Other Positions</U>. To the extent applicable, the Executive shall be deemed to have resigned from all officer and
board member positions that the Executive holds with the Company or any of its subsidiaries and affiliates upon the termination of the Executive&#146;s employment for any reason. The Executive shall execute any documents in reasonable form as may be
requested to confirm or effectuate any such resignations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Severance Pay and Benefits Upon Termination by the Company without Cause
or by the Executive for Good Reason Outside the Change in Control Period</U>. If the Executive&#146;s employment is terminated by the Company without Cause as provided in Section&nbsp;4(d), or the Executive terminates employment for Good Reason as
provided in Section&nbsp;4(e), in each case outside of the Change in Control Period (as defined below), then, in addition to the<B> </B>Accrued Obligations, and subject to (i)&nbsp;the Executive signing a separation agreement and release in a form
and manner reasonably satisfactory to the Company, which shall include, without limitation, a general release of claims against the Company and all related persons and entities that shall not release the Executive&#146;s rights under this Agreement
or the Award Agreement, a reaffirmation of all of the Executive&#146;s Continuing Obligations (as defined below), and, in the Company&#146;s sole discretion, a <FONT STYLE="white-space:nowrap">one-year</FONT> post-employment noncompetition
agreement, and shall provide that if the Executive breaches any of the Continuing Obligations, all payments of the Severance Amount shall immediately cease (the &#147;<U>Separation Agreement</U>&#148;), and (ii)&nbsp;the Separation Agreement
becoming irrevocable, all within 60 days after the Date of Termination (or such shorter period as set forth in the Separation Agreement): </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) the Company shall pay the Executive an amount equal to the sum of 18 months of the Executive&#146;s Base Salary (the &#147;<U>Severance
Amount</U>&#148;); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) an amount equal to 1.5 times his annual target bonus for the year in which the Date of
Termination occurs; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) subject to the Executive&#146;s copayment of premium amounts at the applicable active employees&#146; rate
and the Executive&#146;s proper election to receive benefits under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&#147;<U>COBRA</U>&#148;), the Company shall pay to the group health plan provider or the COBRA provider a
monthly payment equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company until the earliest of (A)&nbsp;the <FONT
STYLE="white-space:nowrap">18-month</FONT> anniversary of the Date of Termination; (B)&nbsp;the date that the Executive becomes eligible for group medical plan benefits under any other employer&#146;s group medical plan; or (C)&nbsp;the cessation of
the Executive&#146;s health continuation rights under COBRA; <I>provided, however</I>, that if the Company determines that it cannot pay such amounts to the group health plan provider or the COBRA provider (if applicable) without potentially
violating applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly to the Executive for the time period specified above. Such
payments to the Executive shall be subject to <FONT STYLE="white-space:nowrap">tax-related</FONT> deductions and withholdings and paid on the Company&#146;s regular payroll dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amounts payable under this Section&nbsp;6, to the extent taxable, shall be paid out in substantially equal installments in accordance with the
Company&#146;s payroll practice over 18 months commencing within 60 days after the Date of Termination; provided, however, that if the <FONT STYLE="white-space:nowrap">60-day</FONT> period begins in one calendar year and ends in a second calendar
year, such payments, to the extent they qualify as <FONT STYLE="white-space:nowrap">&#147;non-qualified</FONT> deferred compensation&#148; within the meaning of Section&nbsp;409A of the Internal Revenue Code of 1986, as amended (the
&#147;<U>Code</U>&#148;), shall begin to be paid in the second calendar year by the last day of such <FONT STYLE="white-space:nowrap">60-day</FONT> period; <I>provided, further</I>, that the initial payment shall include a <FONT
STYLE="white-space:nowrap">catch-up</FONT> payment to cover amounts retroactive to the day immediately following the Date of Termination. Each payment pursuant to this Agreement is intended to constitute a separate payment for purposes of Treasury
Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Severance Pay and Benefits Upon Termination by the
Company without Cause or by the Executive for Good Reason within the Change in Control Period</U>. The provisions of this Section&nbsp;7 shall apply in lieu of, and expressly supersede, the provisions of Section&nbsp;6 if (i)&nbsp;the
Executive&#146;s employment is terminated either (a)&nbsp;by the Company without Cause as provided in Section&nbsp;4(d), or (b)&nbsp;by the Executive for Good Reason as provided in Section&nbsp;4(e), and (ii)&nbsp;the Date of Termination is within
the Change in Control Period. These provisions shall terminate and be of no further force or effect after the Change in Control Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Executive&#146;s employment is terminated by the Company without Cause as provided in Section&nbsp;4(d) or the Executive terminates
employment for Good Reason as provided in Section&nbsp;4(e) and in each case the Date of Termination occurs within the Change in Control Period, then, in addition to the Accrued Obligations, and subject to the signing of the Separation Agreement by
the Executive and the Separation Agreement becoming fully effective, all within the time frame set forth in the Separation Agreement but in no event more than 60 days after the Date of Termination: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Company shall pay the Executive a lump sum in cash in an amount
equal to two times the Executive&#146;s Base Salary (the &#147;<U>Change in Control Payment</U>&#148;); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) an amount
equal to 2.0 times his annual target bonus for the year in which the Date of Termination occurs; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) subject to the
Executive&#146;s copayment of premium amounts at the applicable active employees&#146; rate and the Executive&#146;s proper election to receive benefits under COBRA, the Company shall pay to the group health plan provider or the COBRA provider a
monthly payment equal to the monthly employer contribution that the Company would have made to provide health insurance to the Executive if the Executive had remained employed by the Company until the earliest of (A)&nbsp;the <FONT
STYLE="white-space:nowrap">18-month</FONT> anniversary of the Date of Termination; (B)&nbsp;the date that the Executive becomes eligible for group medical plan benefits under any other employer&#146;s group medical plan; or (C)&nbsp;the cessation of
the Executive&#146;s health continuation rights under COBRA; <I>provided, however</I>, that if the Company determines that it cannot pay such amounts to the group health plan provider or the COBRA provider (if applicable) without potentially
violating applicable law (including, without limitation, Section&nbsp;2716 of the Public Health Service Act), then the Company shall convert such payments to payroll payments directly to the Executive for the time period specified above. Such
payments to the Executive shall be subject to <FONT STYLE="white-space:nowrap">tax-related</FONT> deductions and withholdings and paid on the Company&#146;s regular payroll dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The amounts payable under this Section&nbsp;7(a), to the extent taxable, shall be paid or commence to be paid within 60 days after the Date of Termination;
<I>provided, however</I>, that if the <FONT STYLE="white-space:nowrap">60-day</FONT> period begins in one calendar year and ends in a second calendar year, such payments to the extent they qualify as
<FONT STYLE="white-space:nowrap">&#147;non-qualified</FONT> deferred compensation&#148; within the meaning of Section&nbsp;409A of the Code, shall be paid or commence to be paid in the second calendar year by the last day of such <FONT
STYLE="white-space:nowrap">60-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Additional Limitation</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Anything in this Agreement to the contrary notwithstanding, in the event that the amount of any compensation, payment or
distribution by the Company to or for the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, calculated in a manner consistent with Section&nbsp;280G of the Code,
and the applicable regulations thereunder (the &#147;<U>Aggregate Payments</U>&#148;), would be subject to the excise tax imposed by Section&nbsp;4999 of the Code, then the Aggregate Payments shall be reduced (but not below zero) so that the sum of
all of the Aggregate Payments shall be $1.00 less than the amount at which the Executive becomes subject to the excise tax imposed by Section&nbsp;4999 of the Code; <I>provided</I> that such reduction shall only occur if it would result in the
Executive receiving a higher After Tax Amount (as defined below) than the Executive would receive if the Aggregate Payments were not subject to such reduction. In such event, the Aggregate Payments shall be reduced in the following order, in each
case, in reverse chronological order beginning with the Aggregate Payments that are to be paid the furthest in time from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
consummation of the transaction that is subject to Section&nbsp;280G of the Code: (1)&nbsp;cash payments not subject to Section&nbsp;409A of the Code; (2)&nbsp;cash payments subject to
Section&nbsp;409A of the Code; (3)&nbsp;equity-based payments and acceleration; and <FONT STYLE="white-space:nowrap">(4)&nbsp;non-cash</FONT> forms of benefits; <I>provided</I> that in the case of all the foregoing Aggregate Payments all amounts or
payments that are not subject to calculation under Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.280G-1,</FONT> <FONT STYLE="white-space:nowrap">Q&amp;A-24(b)</FONT> or (c)&nbsp;shall be reduced before any amounts that are subject to
calculation under Treas. Reg. <FONT STYLE="white-space:nowrap">&#167;1.280G-1,</FONT> <FONT STYLE="white-space:nowrap">Q&amp;A-24(b)</FONT> or (c). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) For purposes of this Section&nbsp;7(b), the &#147;<U>After Tax Amount</U>&#148; means the amount of the Aggregate Payments
less all federal, state, and local income, excise and employment taxes imposed on the Executive as a result of the Executive&#146;s receipt of the Aggregate Payments. For purposes of determining the After Tax Amount, the Executive shall be deemed to
pay federal income taxes at the highest marginal rate of federal income taxation applicable to individuals for the calendar year in which the determination is to be made, and state and local income taxes at the highest marginal rates of individual
taxation in each applicable state and locality, net of the maximum reduction in federal income taxes that could be obtained from deduction of such state and local taxes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The determination as to whether a reduction in the Aggregate Payments shall be made pursuant to Section&nbsp;7(b)(i)
shall be made by a nationally recognized accounting firm selected by the Company (the &#147;<U>Accounting Firm</U>&#148;), which shall provide detailed supporting calculations both to the Company and the Executive within 15 business days of the Date
of Termination, if applicable, or at such earlier time as is reasonably requested by the Company or the Executive. Any determination by the Accounting Firm shall be binding upon the Company and the Executive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Definitions</U>. For purposes of this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) &#147;<U>Change in Control</U>&#148; means: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) the sale of all or substantially all of the assets of the Company and its subsidiaries to one or more third parties in a
transaction (or a series of related transactions); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) any person or company that Controls the Company becoming bound or
entitled to acquire ordinary shares of the Company under Sections 974 to 991 of the UK Companies Act 2006; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(C) any court
sanctioning a compromise or arrangement under Section&nbsp;899 of the UK Companies Act 2006 pursuant to which any person or company (either alone or together with any person or company acting in concert with him or it); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(D) any merger, reorganization, consolidation or other similar transaction pursuant to which the holders of the Company&#146;s
outstanding voting power and outstanding stock or other equity interests immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock or other equity interests of the Company or any resulting or
successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction (or series of related transactions); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(E) any other transaction in which the owners of the Company&#146;s
outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity immediately upon completion of the transaction other than as a result of the
acquisition of securities directly from the Company; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(F) any other similar transaction which the Board determines
should constitute a Change of Control for the purposes of this Agreement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) &#147;<U>Control</U>&#148; means the
ownership of more than 50&nbsp;percent of the outstanding voting power of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) &#147;<U>Change in Control
Period</U>&#148; shall mean the period beginning on the date of the first event constituting a Change in Control and ending on the <FONT STYLE="white-space:nowrap">24-month</FONT> anniversary of the first event constituting a Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Section 409A</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
Anything in this Agreement to the contrary notwithstanding, if at the time of the Executive&#146;s separation from service within the meaning of Section&nbsp;409A of the Code, the Company determines that the Executive is a &#147;specified
employee&#148; within the meaning of Section&nbsp;409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that the Executive becomes entitled to under this Agreement or otherwise on account of the Executive&#146;s separation from
service would be considered deferred compensation otherwise subject to the 20% additional tax imposed pursuant to Section&nbsp;409A(a) of the Code as a result of the application of Section&nbsp;409A(a)(2)(B)(i) of the Code, such payment shall not be
payable and such benefit shall not be provided until the date that is the earlier of (A)&nbsp;six months and one day after the Executive&#146;s separation from service, or (B)&nbsp;the Executive&#146;s death. If any such delayed cash payment is
otherwise payable on an installment basis, the first payment shall include a <FONT STYLE="white-space:nowrap">catch-up</FONT> payment covering amounts that would otherwise have been paid during the <FONT STYLE="white-space:nowrap">six-month</FONT>
period but for the application of this provision, and the balance of the installments shall be payable in accordance with their original schedule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided and expenses eligible for reimbursement under this Agreement shall
be provided by the Company or incurred by the Executive during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the last day
of the taxable year following the taxable year in which the expense was incurred. The amount of <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits provided or reimbursable expenses incurred in one taxable year shall not affect the <FONT
STYLE="white-space:nowrap">in-kind</FONT> benefits to be provided or the expenses eligible for reimbursement in any other taxable year (except for any lifetime or other aggregate limitation applicable to medical expenses). Such right to
reimbursement or <FONT STYLE="white-space:nowrap">in-kind</FONT> benefits is not subject to liquidation or exchange for another benefit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent that any payment or benefit described in this Agreement constitutes <FONT
STYLE="white-space:nowrap">&#147;non-qualified</FONT> deferred compensation&#148; under Section&nbsp;409A of the Code, and to the extent that such payment or benefit is payable upon the Executive&#146;s termination of employment, then such payments
or benefits shall be payable only upon the Executive&#146;s &#147;separation from service.&#148; The determination of whether and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury
Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-1(h).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The parties intend that this Agreement will be
administered in accordance with Section&nbsp;409A of the Code. To the extent that any provision of this Agreement is ambiguous as to its compliance with Section&nbsp;409A of the Code, the provision shall be read in such a manner so that all payments
hereunder comply with or are exempt from Section&nbsp;409A of the Code. Each payment pursuant to this Agreement or the Restrictive Covenants Agreement (as defined below) is intended to constitute a separate payment for purposes of Treasury
Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-2(b)(2).</FONT> The parties agree that this Agreement may be amended, as reasonably requested by either party, and as may be necessary to fully comply with Section&nbsp;409A of the Code
and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost to either party. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The Company makes no representation or warranty and shall have no liability to the Executive or any other person if any provisions of this
Agreement are determined to constitute deferred compensation subject to Section&nbsp;409A of the Code but do not satisfy an exemption from, or the conditions of, such Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Continuing Obligations</U>.<U> </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Restrictive Covenants Agreement</U>. As a condition of employment, the Executive is required to enter into the Nondisclosure,
Developments and Noncompetition Agreement, attached hereto as <U>Exhibit B</U> (the &#147;<U>Restrictive Covenants Agreement</U>&#148;). The Executive acknowledges and agrees that the Executive received the Restrictive Covenants Agreement with this
Agreement and at least 10 business days before the commencement of the Executive&#146;s employment. For purposes of this Agreement, the obligations in this Section&nbsp;9 and those that arise in the Restrictive Covenants Agreement and any other
agreement relating to confidentiality, assignment of inventions, or other restrictive covenants shall collectively be referred to as the &#147;<U>Continuing Obligations</U>.&#148; For the avoidance of doubt, all restrictive covenants obligations are
supplemental to one another, and in the event of any conflict between restrictive covenants obligations, the most restrictive provision that is enforceable shall govern. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Third-Party Agreements and Rights</U>. The Executive hereby confirms that the Executive is not bound by the terms of any agreement with
any previous employer or other party which restricts in any way the Executive&#146;s use or disclosure of information, other than confidentiality restrictions (if any), or the Executive&#146;s engagement in any business. The Executive represents to
the Company that the Executive&#146;s execution of this Agreement, the Executive&#146;s employment with the Company and the performance of the Executive&#146;s proposed duties for the Company will not violate any obligations the Executive may have
to any such previous employer or other party. In the Executive&#146;s work for the Company, the Executive will not disclose or make use of any information in violation of any agreements with or rights of any such previous employer or other party,
and the Executive will not bring to the premises of the Company any copies or other tangible embodiments of <FONT STYLE="white-space:nowrap">non-public</FONT> information belonging to or obtained from any such previous employment or other party.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Litigation and Regulatory Cooperation</U>. During and after the Executive&#146;s
employment, the Executive shall reasonably cooperate with the Company in (i)&nbsp;the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company which relate to events
or occurrences that transpired while the Executive was employed by the Company, and (ii)&nbsp;the investigation, whether internal or external, of any matters about which the Company believes the Executive may have knowledge or information. The
Executive&#146;s reasonable cooperation in connection with such claims, actions or investigations shall include, but not be limited to, being available to meet with counsel to answer questions or to prepare for discovery or trial and to act as a
witness on behalf of the Company at mutually convenient times. During and after the Executive&#146;s employment, the Executive also shall reasonably cooperate with the Company in connection with any investigation or review of any federal, state or
local regulatory authority as any such investigation or review relates to events or occurrences that transpired while the Executive was employed by the Company. The Company shall reimburse the Executive for any reasonable costs, expenses and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in connection with the Executive&#146;s performance of obligations pursuant to this Section&nbsp;9(c), including, without limitation, to the
extent the Board determines in its reasonable good faith discretion that, under the circumstances at hand, it would be reasonable and prudent for the Executive to engage independent counsel, the Company will reimburse the Executive&#146;s reasonable
attorney fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Relief</U>. The Executive agrees that it would be difficult to measure any damages caused to the Company which
might result from any breach by the Executive of the Continuing Obligations, and that in any event money damages would be an inadequate remedy for any such breach. Accordingly<B>,</B> the Executive agrees that if the Executive breaches, or proposes
to breach, any portion of the Continuing Obligations, the Company shall be entitled, in addition to all other remedies that it may have, to an injunction or other appropriate equitable relief to restrain any such breach without showing or proving
any actual damage to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>Consent to Jurisdiction</U>. The parties hereby consent to the jurisdiction of the state and
federal courts of the State of New Jersey. Accordingly, with respect to any such court action, the Executive (a)&nbsp;submits to the exclusive personal jurisdiction of such courts; (b)&nbsp;consents to service of process; and (c)&nbsp;waives any
other requirement (whether imposed by statute, rule of court, or otherwise) with respect to personal jurisdiction or service of process. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Waiver of Jury Trial</U>. Each of the Executive and the Company irrevocably and unconditionally WAIVES ALL RIGHT TO TRIAL BY JURY IN
ANY PROCEEDING (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE EXECUTIVE&#146;S EMPLOYMENT BY THE COMPANY OR ANY AFFILIATE OF THE COMPANY, INCLUDING WITHOUT LIMITATION THE EXECUTIVE&#146;S OR THE
COMPANY&#146;S PERFORMANCE UNDER, OR THE ENFORCEMENT OF, THIS AGREEMENT. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Integration</U>. This Agreement, together with the Equity Documents and the
Restrictive Covenants Agreement, constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements between the parties concerning such subject matter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Withholding; Tax Effect</U>. All payments made by the Company to the Executive under this Agreement shall be net of any tax or other
amounts required to be withheld by the Company under applicable law. Nothing in this Agreement shall be construed to require the Company to make any payments to compensate the Executive for any adverse tax effect associated with any payments or
benefits or for any deduction or withholding from any payment or benefit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Assignment; Successors and Assigns</U>. Neither the
Executive nor the Company may make any assignment of this Agreement or any interest in it, by operation of law or otherwise, without the prior written consent of the other; <I>provided, however</I>, that the Company shall require any successor
(whether direct or indirect and whether by purchase, lease, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#146;s business and/or assets of the Company expressly to assume and agree to perform this
Agreement to the same extent that the Company would be required to perform it if no succession had taken place; <I>provided, further</I> that if the Executive remains employed or becomes employed by the Company, the purchaser or any of their
affiliates in connection with any such transaction, then the Executive shall not be entitled to any payments, benefits or vesting pursuant to Section&nbsp;6 or pursuant to Section&nbsp;7 of this Agreement solely as a result of such transaction. This
Agreement shall inure to the benefit of and be binding upon the Executive and the Company, and each of the Executive&#146;s and the Company&#146;s respective successors, executors, administrators, heirs and permitted assigns. In the event of the
Executive&#146;s death after the Executive&#146;s termination of employment but prior to the completion by the Company of all payments due to the Executive under this Agreement, the Company shall continue such payments to the Executive&#146;s
beneficiary designated in writing to the Company prior to the Executive&#146;s death (or to the Executive&#146;s estate, if the Executive fails to make such designation). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Enforceability</U>. If any portion or provision of this Agreement (including, without limitation, any portion or provision of any
section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the application of such portion or provision in circumstances other than those as to
which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <U>Survival</U>. The provisions of this Agreement shall survive the termination of this Agreement and/or the termination of the
Executive&#146;s employment to the extent necessary to effectuate the terms contained herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Waiver</U>. No waiver of any
provision hereof shall be effective unless made in writing and signed by the waiving party. The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement,
shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18. <U>Notices</U>. Any notices, requests, demands and other communications provided for by
this Agreement shall be sufficient only if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified mail, postage prepaid, return receipt requested, to the Executive at the last
address the Executive has filed in writing with the Company or, in the case of the Company, at its main offices in the United States, attention of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19. <U>Amendment</U>. This Agreement may be amended or modified only by a written instrument signed by the Executive and by a duly authorized
representative of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">20. <U>Effect on Other Plans and Agreements</U>. An election by the Executive to resign for Good Reason
under the provisions of this Agreement shall not be deemed a voluntary termination of employment by the Executive for the purpose of interpreting the provisions of any of the Company&#146;s benefit plans, programs or policies. Nothing in this
Agreement shall be construed to limit the rights of the Executive under the Company&#146;s benefit plans, programs or policies except that the Executive shall have no rights to any severance benefits under any Company severance pay plan, offer
letter or otherwise, including, without limitation, under the Company&#146;s Executive Severance and Change of Control Plan. Notwithstanding anything to the contrary in this Agreement, all severance pay and benefits provided to the Executive
pursuant to Section&nbsp;6 or Section&nbsp;7 of this Agreement (as applicable) shall be reduced and/or offset by any amounts or benefits paid to the Executive to satisfy the federal Worker Adjustment and Retraining Notification (WARN) Act, 29 U.S.C.
&#167; 2101 et seq., as amended, and any applicable state plant or facility closing or mass layoff law (whether as damages, as payment of salary or other wages during an applicable notice period or otherwise). Except for the Restrictive Covenants
Agreement, in the event that the Executive is party to an agreement with the Company providing for payments or benefits under such plan or agreement and under this Agreement, the terms of this Agreement shall govern and the Executive may receive
payment under this Agreement only and not both. Further, Section&nbsp;6 and Section&nbsp;7 of this Agreement are mutually exclusive and in no event shall the Executive be entitled to payments or benefits pursuant to both Section&nbsp;6 and
Section&nbsp;7 of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">21. <U>Governing Law</U>. This is a New Jersey contract and shall be construed under and be governed in
all respects by the laws of the State of New Jersey without giving effect to the conflict of laws principles thereof. With respect to any disputes concerning federal law, such disputes shall be determined in accordance with the law as it would be
interpreted and applied by the United States Court of Appeals for the Third Circuit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">22. <U>Conditions</U>. Notwithstanding anything to
the contrary herein, the effectiveness of this Agreement shall be conditioned on (i)&nbsp;the Executive&#146;s satisfactory completion of reference and background checks, if so requested by the Company, and (ii)&nbsp;the Executive&#146;s submission
of satisfactory proof of the Executive&#146;s legal authorization to work in the United States. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">23. <U>Counterparts</U>. This Agreement may be executed in any number of counterparts, each
of which when so executed and delivered shall be taken to be an original; but such counterparts shall together constitute one and the same document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have executed this Agreement effective on the Effective Date. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>AMARIN CORPORATION PLC</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Odysseas Kostas</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Its:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">Director</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PATRICK J. HOLT</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Patrick J. Holt</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Patrick J. Holt</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit A </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AWARD AGREEMENT </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH &#147;[***]&#148;. SUCH
IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I)&nbsp;NOT MATERIAL AND (II)&nbsp;OF THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g530487g65z30.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMARIN CORPORATION plc 2020 STOCK INCENTIVE PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AWARD AGREEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This<B>&nbsp;AWARD
AGREEMENT</B>&nbsp;(the &#147;<B>Agreement</B>&#148;) is entered into and made effective between Amarin Corporation plc (the &#147;<B>Company</B>&#148;) and (the &#147;<B>Optionee</B>&#148;). The Company hereby grants to the Optionee a <FONT
STYLE="white-space:nowrap">Non-Qualified</FONT> Stock Option (the &#147;<B>Option</B>&#148;) to purchase the number of shares set forth below. Capitalized terms used and not defined herein shall have the meanings set forth in the Amarin Corporation
plc 2020 Stock Incentive Plan, as amended (the &#147;<B>Plan</B>&#148;), which is incorporated by this reference in its entirety. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1.</B><B></B><B>&nbsp;</B><B></B><B></B><B></B><B>Number of Ordinary Shares Underlying the Option: </B>5,000,000 (the &#147;<B>Option Shares</B>&#148;)
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2.</B><B></B><B>&nbsp;</B><B></B><B></B><B></B><B>Per Share Exercise Price:</B>&nbsp;$[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] if left blank
the &#147;Per Share Exercise Price&#148; shall be closing price on the Grant Date of the Shares on the National Association of Securities Dealers Automatic Quotation System (&#147;<B>Nasdaq</B>&#148;) (provided that such Per Share Exercise Price
shall not be less than the par&nbsp;value of a Share at any time, currently &pound;0.50) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3.</B><B></B><B>&nbsp;</B><B></B><B></B><B></B><B>Grant Date:
</B>August&nbsp;1, 2023 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4.</B><B> Expiration Date:</B> August&nbsp;1, 2033 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5.</B> <B>Performance Period:</B> The nine calendar-year period commencing on the Grant Date and Ending on August&nbsp;1, 2032. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6.</B><B></B><B>&nbsp;</B><B></B><B></B><B></B><B>Date Option Shares Become Exercisable (Vesting):</B> This Award is subject to both a performance-based
vesting condition (the &#147;<B>Performance Vesting Condition</B>&#148;) and a time-based vesting condition (the &#147;<B>Time Condition</B>&#148;), as described in Paragraph 6(a) and Paragraph 6(b) below. Except as otherwise provided in Paragraph
6(c) and Paragraph 6(d) below, both the Performance Vesting Condition and Time Condition must be satisfied before the Expiration Date before the Option Shares will be deemed vested and exercisable. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Performance Vesting</B>. Subject to Paragraph 6(c) below, the number of Option Shares set forth in the
Option Table below shall be deemed to have satisfied the Performance Vesting Condition on the date that the Board or the Committee confirms that there has been a Share Price Hurdle Achievement (as defined below) (such date, the &#147;<B>Performance
Date</B>&#148;), subject to the Optionee&#146;s Continuous Status as an Employee or Consultant through the applicable Performance Date. &#147;<B>Share Price Hurdle&#148;</B> means each dollar figure set forth in the Option Table below.
&#147;<B>Share Price Hurdle Achievement</B>&#148; means that the trailing <FONT STYLE="white-space:nowrap">60-Day</FONT> VWAP of the Shares during the Performance Period equals or exceeds the applicable Share Price Hurdle. &#147;<B><FONT
STYLE="white-space:nowrap">60-Day</FONT> VWAP</B>&#148; means the volume weighted average price of the Shares over a period of 60 calendar days. The Board or Committee shall confirm Share Price Hurdle Achievement as soon as reasonably practicable
but no less frequently than quarterly during the Performance Period and within 30 days after the end of the Performance Period. The Performance Vesting Condition shall be deemed satisfied on the Performance Date for the applicable Share Price Hurdle
Achievement. To the extent any portion of Option Shares has not satisfied the Performance Vesting Condition on or prior to the last day of the Performance Period, such portion shall expire and be of no further force or effect as 12:01 a.m. on the
day following the end of the Performance Period. In no event may more than 100% of the Option Shares be deemed to have satisfied the Performance Vesting Condition. <B></B> </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>OPTION TABLE </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="46%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&#147;Share Price Hurdle&#148;</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number&nbsp;of&nbsp;Option&nbsp;Shares&nbsp;That&nbsp;Satisfy&nbsp;the&nbsp;Performance</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Vesting Condition</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">$2.50</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">[****]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">[****]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">[****]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">[****]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">[****]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">[****]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">[****]</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">[****]</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">[****]</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center">$15.00</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">[****]</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Time Condition. </B>Subject to Paragraphs 6(c) and 6(d) below, any Option Shares for which the Performance
Vesting Condition has been satisfied shall satisfy the Time Condition and shall be vested and exercisable on the earlier of the (i)&nbsp;date that is five months following the Performance Date for such Option Shares, subject to the Optionee&#146;s
Continuous Status as an Employee or Consultant through such date or (ii)&nbsp;the termination of the Optionee&#146;s Continuous Status as an Employee or Consultant by reason the Optionee&#146;s death or permanent or total disability. For the
avoidance of doubt, and notwithstanding anything else contained herein or in the Employment Agreement to the contrary, in the event of Optionee&#146;s death or disability, , the Option Shares for which the Performance Vesting Condition has been
achieved shall automatically satisfy the Time Condition and become vested and exercisable by the Executive or his estate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Change in Control</B>. Notwithstanding anything to the contrary in the Plan or in the Employment Agreement
between the Company and the Executive, dated as of July [&nbsp;&nbsp;&nbsp;&nbsp;], 2023 (the &#147;<B>Employment Agreement</B>&#148;): </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">i.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if either (A)&nbsp;a Change in Control (as defined in the Employment Agreement) occurs prior to end of the
Performance Period, subject to the Optionee&#146;s Continuous Status as an Employee or Consultant through the Change in Control or, (B)&nbsp;the Optionee&#146;s Continuous Status as an Employee or Consultant is terminated by the Company without
Cause (as defined in the Employment Agreement) or by the Optionee for Good Reason (as defined in the Employment Agreement) (in either case an &#147;<B>Involuntary Termination</B>&#148;) and such Involuntary Termination occurs within three months
prior to the Change in Control (a &#147;<B><FONT STYLE="white-space:nowrap">Pre-Change</FONT> in Control Involuntary Termination</B>&#148;), and subject to the Optionee signing a Separation Agreement (as defined in the Employment Agreement) and the
Separation Agreement becoming irrevocable, all within 60 days after the Date of Termination (as defined in the Employment Agreement) (or such shorter period as set forth in the Separation Agreement) (the &#147;<B>Separation Agreement
Condition</B>&#148;), then the Performance Vesting Condition shall be deemed satisfied for all unvested Option Shares (i.e., all Share Price Hurdles shall be deemed achieved) as of immediately prior to the effective time of the Change in Control.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">ii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If this Option is not assumed, substituted or continued by the Company or its successor entity in such Change
in Control, subject to (i)&nbsp;the Optionee&#146;s Continuous Status as an Employee or Consultant through the Change in Control or (ii)&nbsp;a <FONT STYLE="white-space:nowrap">Pre-Change</FONT> in Control Involuntary Termination and subject to the
Separation Agreement Condition, the Time Condition shall be deemed to be fully satisfied as of immediately prior to the effective time of the Change in Control. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iii.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If this Option is assumed, substituted or continued by the Company or its successor entity in a Change in
Control, the Time Condition shall be deemed to be satisfied upon the earlier of (i)&nbsp;the date that is 12 months following the consummation of the Change in Control and (ii)&nbsp;an Involuntary Termination, subject to the Separation Agreement
Condition. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">iv.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In the event of an Involuntary Termination, the then unvested Option Shares will be held in abeyance to the
extent necessary to effectuate the provisions in this Section&nbsp;6(c) and 6(d) below. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">T<B>ermination Without Cause or for Good Reason Prior to a Change in Control</B>. Notwithstanding anything to
the contrary in the Plan or in the Employment Agreement, in the event of an Involuntary Termination that occurs at any time more than three months prior to a Change in Control, subject to the Separation Agreement Condition, (i)&nbsp;the number of
Option Shares that would have been deemed to have satisfied the Performance Vesting Condition if the next unachieved Share Price Hurdle had been achieved<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> shall be deemed to satisfy the
Performance Vesting Condition and (ii)&nbsp;the Time Condition for any Option Shares for which the Share Price Hurdle has been achieved or deemed achieved pursuant to this Paragraph 6(d) shall immediately accelerate and become fully vested and
exercisable as of the later of the Date of Termination and the effectiveness of the Separation Agreement. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7.</B><B></B><B>&nbsp;Terms of this Award Agreement:</B>&nbsp;In the event of a conflict between the provisions of this Agreement and the Plan, except in
relation to Paragraphs 6, 8 and 9 of this Agreement (which terms of this Agreement shall prevail), the provisions of the Plan shall prevail. A copy of the Plan is&nbsp;provided herewith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8.</B><B></B><B>&nbsp;</B><B></B><B></B><B></B><B><FONT STYLE="white-space:nowrap">Non-transferable:</FONT></B>&nbsp;This Option shall not be transferable
by the Optionee other than by will or the laws of descent and distribution, and the Option shall be exercisable, during the Optionee&#146;s lifetime, only by the Optionee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Forfeiture; Recovery of Compensation: </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This Agreement and the Option shall be subject to reduction, cancellation, forfeiture or recoupment to the
extent necessary to comply with (i)&nbsp;any clawback, forfeiture or other similar policy adopted by the Board or Committee and as in effect from time to time (the &#147;Clawback Policy&#148;); and (ii)&nbsp;applicable law and the Optionee agrees
that the Optionee shall take all required action to enable such reduction, cancellation, forfeiture or recoupment. The Optionee further agrees that (i)&nbsp;all Incentive-Based Compensation (as defined in the Clawback Policy) received by the
Optionee after the effective date of the Clawback Policy is subject to recovery pursuant to the Clawback Policy and (ii)&nbsp;the Optionee is not entitled to indemnification for any Erroneously Awarded Compensation (as defined in the Clawback
Policy) or for any claim or losses arising out of or in any way related to Erroneously Awarded Compensation recovered pursuant to the Clawback Policy and, to the extent any agreement or organizational document purports to provide otherwise, the
Optionee hereby irrevocably agrees to forego such indemnification. </P></TD></TR></TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For example, in the event of a termination by the Company without Cause or by the Optionee for Good Reason, if
the Performance Vesting Condition has been achieved for both the [****] and the [****] Share Price Hurdles as of the Date of the Termination, an additional [****] Option Shares (those attributable to the [****] Share Price Hurdle) shall be deemed to
satisfy the Performance Vesting Condition. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Notwithstanding anything in the Plan to the contrary, if the Company terminates the Optionee&#146;s Continuous
Status as an Employee or Consultant for Cause, then any portion of this Option outstanding on such date (whether vested or unvested) shall terminate immediately and be of no further force and effect; provided, however, for the avoidance of doubt,
any Option Shares that have vested and been exercised and are held by the Optionee as of the Date of Termination shall not terminate. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If, within 30 days after the termination of the Optionee&#146;s Continuous Status as an Employee or Consultant,
the Board or the Committee has reasonable evidence to conclude that the Optionee breached the nondisclosure or confidentiality terms of the Nondisclosure, Developments and Noncompetition Agreement, then any portion of this Option outstanding on such
date (whether vested or unvested) shall terminate immediately and be of no further force and effect. If a court of competent jurisdiction (the &#147;Court&#148;) enters an order concluding that the Optionee breached the nondisclosure or
confidentiality terms of the Nondisclosure, Developments and Noncompetition Agreement then, in addition to all other legal and equitable remedies for such breach, the Optionee agrees to pay the Company a sum equal to the Net Proceeds realized by the
Optionee during the <FONT STYLE="white-space:nowrap">one-year</FONT> period preceding the date the Company reasonably concluded that the Optionee breached the Nondisclosure, Developments and Noncompetition Agreement (the &#147;Net Proceeds
Payment&#148;), provided the Court will determine actual monetary damages to the Company as a result of Optionee&#146;s breach (the &#147;Monetary Damages Amount&#148;) and to the extent that the Monetary Damages Amount exceeds the Net Proceeds
Payment (the &#147;Delta&#148;), the Optionee shall be liable for the Net Proceeds Payment and the Delta. For the avoidance of doubt, in no event shall the Optionee be liable for monetary damages under this Section&nbsp;9 (c) greater than the
Monetary Damages Amount. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">d.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For purposes of this Agreement, &#147;<B>Net Proceeds</B>&#148; means the full amount of any proceeds realized
by the Optionee from the exercise of all or any portion of this Option Shares or the sale of any Option Shares, net of the amount of any brokerage commission relating to such sale and after deduction of the exercise price paid by the Optionee with
respect to such Option Shares. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By accepting this Agreement, you agree to all of the terms and conditions described herein and in the
Plan (including any applicable local law addendum). </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>AMARIN CORPORATION plc&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><B>OPTIONEE</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:&nbsp;/s/ [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Signature: Refer to Shareworks for acceptance.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:&nbsp;[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Exhibit B </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NONDISCLOSURE, DEVELOPMENTS AND NONCOMPETITION AGREEMENT </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>amrn-20230718.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 71.3.0 -->
<!-- Creation date: 7/20/2023 2:33:58 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:amrn="http://www.amarincorp.com/20230718"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:us-types="http://fasb.org/us-types/2022"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.amarincorp.com/20230718"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amrn-20230718_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="amrn-20230718_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>amrn-20230718_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 71.3.0 -->
<!-- Creation date: 7/20/2023 2:33:59 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Three</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Three</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Country</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCountry_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Country</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Country Region</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CountryRegion_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Country Region</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>amrn-20230718_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - Donnelley Financial Solutions, Inc. -->
<!-- CTU Version: 71.3.0 -->
<!-- Creation date: 7/20/2023 2:33:59 AM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="amrn-20230718.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="20.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="21.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="26.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine3" order="26.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="26.031" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="26.071" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:type="locator" xlink:label="dei_EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCountry" order="26.171" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:type="locator" xlink:label="dei_CountryRegion" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CountryRegion" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="32.011" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="32.021" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g530487g65z30.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g530487g65z30.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#$17AI9@  34T *@    @ ! $[  (
M   ;   (2H=I  0    !   (9IR=  $    V   0ANH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %1H86YG851H
M:7)U<&%T:&D@4F%J86=O<&%L     >H<  <   @,   (>      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!
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MV<#!&&C9?\<UZ%*U6BX2/,JITJO/ ^SP>N#]:\7_ &A_^/+1_P#KK)_2O0?
M7BF/Q;X2M-0C8><$$<Z?W7'!_/&?H17G_P"T./\ 0='/_363^5<F'BXUDF=N
M(DI4.9'!_"?4I=(\7-=06-Q?D0,##;C+8]?UKM_&GQGNH+6YTO3])N;*\*;7
MDN1M,?'8=S7,_ SGXA$$D#[.W0XSTKO_ (T^"_[9T4:S90[KNS4^8!U=._\
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ME\(2:7IWA;5X9[K D,ENV(UZD9QZXKH? 7BV]>QT_1M4T'4K.=4\KSG@81\
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MQLMA%I?AW556V+,[26K#.?PKW^BK==<_.D9?5GR<G,?,OPYM]9\(>*?[2O\
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8 Y!^M2T5K4J.I9LRI4O9WLPHHHK(W/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139659583870192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jul. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 18,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMARIN CORP PLC\UK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-21392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Iconic Offices, The Greenway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Block C Ardilaun Court<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">112 - 114 St Stephens Green<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Dublin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">IE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">6699 020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1)&#160;Ordinary Share of Amarin Corporation plc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMRN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000897448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>d530487d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="amrn-20230718.xsd" xlink:type="simple"/>
    <context id="duration_2023-07-18_to_2023-07-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000897448</identifier>
        </entity>
        <period>
            <startDate>2023-07-18</startDate>
            <endDate>2023-07-18</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityRegistrantName">AMARIN CORP PLC\UK</dei:EntityRegistrantName>
    <dei:EntityTaxIdentificationNumber
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityTaxIdentificationNumber">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_EntityCentralIndexKey_duration_2023-07-18_to_2023-07-18">0000897448</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="duration_2023-07-18_to_2023-07-18"
      id="Hidden_dei_AmendmentFlag_duration_2023-07-18_to_2023-07-18">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="duration_2023-07-18_to_2023-07-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-07-18_to_2023-07-18">2023-07-18</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-07-18_to_2023-07-18">X0</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-07-18_to_2023-07-18">0-21392</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-07-18_to_2023-07-18">Iconic Offices, The Greenway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2023-07-18_to_2023-07-18">Block C Ardilaun Court</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="duration_2023-07-18_to_2023-07-18">112 - 114 St Stephens Green</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-07-18_to_2023-07-18">Dublin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-07-18_to_2023-07-18">2</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="duration_2023-07-18_to_2023-07-18">IE</dei:EntityAddressCountry>
    <dei:CountryRegion contextRef="duration_2023-07-18_to_2023-07-18">353</dei:CountryRegion>
    <dei:CityAreaCode contextRef="duration_2023-07-18_to_2023-07-18">1</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-07-18_to_2023-07-18">6699 020</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-07-18_to_2023-07-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-07-18_to_2023-07-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-07-18_to_2023-07-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-07-18_to_2023-07-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-07-18_to_2023-07-18">American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1)&#160;Ordinary Share of Amarin Corporation plc</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-07-18_to_2023-07-18">AMRN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-07-18_to_2023-07-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-07-18_to_2023-07-18">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M#FII<>%?'83NJJ2[.H;N7D2</&7QDNLZ$%S#.7/I1=]%:'HE3>\8F@5[(Y,
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MJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%
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M?^:+X3]>?P%02P$"% ,4    " #O0_16!T%-8H$   "Q    $
M    @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( .]#]%9D]DL4
M[0   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+
M 0(4 Q0    ( .]#]%:97)PC$ 8  )PG   3              "  <L!  !X
M;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ [T/T5M_6?K'*!   R1(
M !@              ("!# @  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+
M 0(4 Q0    ( .]#]%:?H!OPL0(  .(,   -              "  0P-  !X
M;"]S='EL97,N>&UL4$L! A0#%     @ [T/T5I>*NQS     $P(   L
M         ( !Z \  %]R96QS+RYR96QS4$L! A0#%     @ [T/T5APX9>H_
M 0  / (   \              ( !T1   'AL+W=O<FMB;V]K+GAM;%!+ 0(4
M Q0    ( .]#]%8D'INBK0   /@!   :              "  3T2  !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( .]#]%9ED'F2&0$
M ,\#   3              "  2(3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%
3!@     )  D /@(  &P4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d530487d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d530487d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d530487d8k.htm">d530487d8k.htm</File>
    <File>amrn-20230718.xsd</File>
    <File>amrn-20230718_lab.xml</File>
    <File>amrn-20230718_pre.xml</File>
    <File>d530487dex101.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d530487d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 25
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d530487d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "amrn-20230718_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "amrn-20230718_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "amrn-20230718.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 25,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "amrn",
   "nsuri": "http://www.amarincorp.com/20230718",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d530487d8k.htm",
      "contextRef": "duration_2023-07-18_to_2023-07-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d530487d8k.htm",
      "contextRef": "duration_2023-07-18_to_2023-07-18",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three",
        "terseLabel": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Securities Act File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amarincorp.com//20230718/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-190185-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-190185-xbrl.zip
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M%\X84 IK=$,89@G!%(TX72@=5OZ"!BQI(=^WHO[X"_I]TV8'G8>MN-4NWQ6
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MC[.CJ=5KFPNMWJ]E%CG&;%!\8G!1I':D,PQ]OF!*K/L\/1'A-T(UG>@W[%O
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M45.S*M4IN?2-2DAU/<4J%<&#$)-RV++X'NIO%B@*W:>D)27J#NRM\KI7T['
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M<Z:B]G2<]AJLE=@J+0IL4&'L_-)V*$^E:]UMH,I1X.%8)/1S5GNG6]?0WI2
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M1J-VSU@>J>R3.4;5S$A7<C8N^N&JWO?1P+(+:)=#%]T:?+!ZX:Z=U82>FN;
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M>Z$DB@6NW]8NJVSR:DSR!_2LO7KTK'U;]M!;MW(E;+)R;#FX3S>YX]>_LXL
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M:V<+9G$$\KI_B!>@#]0#I'(8K& =WXB#-7&.;[A9B#M5P*N9%&@"[9:> 4Z
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M[3*\=@L'52%CNFAX]0#"(]E^4[]E]!U2[1!L-4O#^B)@?^R$D"Y:MB_A6.E
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MP;O_#U!+ 0(4 Q0    ( .]#]%9T8*OG]P(  /X)   1              "
M 0    !A;7)N+3(P,C,P-S$X+GAS9%!+ 0(4 Q0    ( .]#]%9T$-!\M 8
M  !,   5              "  28#  !A;7)N+3(P,C,P-S$X7VQA8BYX;6Q0
M2P$"% ,4    " #O0_16++&O-K@$  !Y+P  %0              @ $-"@
M86UR;BTR,#(S,#<Q.%]P<F4N>&UL4$L! A0#%     @ [T/T5B5+9%@-%@
M,84   X              ( !^ X  &0U,S T.#=D.&LN:'1M4$L! A0#%
M  @ [T/T5E12[GHR3   ^7D! !$              ( !,24  &0U,S T.#=D
?97@Q,#$N:'1M4$L%!@     %  4 0 $  ))Q      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
